Search results
Has CDK Global (CDK) Outpaced Other Computer and Technology Stocks This Year?
Zacks via Yahoo Finance· 2 years agoFor those looking to find strong Computer and Technology stocks, it is prudent to search for...
CDK Global (CDK) Tops Q3 Earnings Estimates
Zacks via Yahoo Finance· 2 years agoCDK Global (CDK) delivered earnings and revenue surprises of 5.41% and 0.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues...
How to buy a car in 2024: What’s changed?
Bankrate via Yahoo Finance· 2 months agoA car can be the second most expensive purchase many consumers make in their lifetime. Securing this high-ticket item has historically been a somewhat...
What's Driving Guidewire Software Inc's Surprising 31% Stock Rally?
GuruFocus.com via Yahoo Finance· 8 months agoGuidewire Software Inc (NYSE:GWRE), a leading player in the software industry, has seen a...
Should iShares MSCI USA SmallCap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
Zacks via Yahoo Finance· 2 years agoThe iShares MSCI USA SmallCap Min Vol Factor ETF (SMMV) was launched on 09/07/2016, and is a...
Zendesk To Be Acquired By Private Equity Firms; 'Investors Left Disappointed?'
Investor's Business Daily· 2 years agoEmbattled software maker Zendesk on Friday agreed to be bought by private equity firms Hellman &...
2 Powerhouse Dividend Stocks to Invest in This Month
Motley Fool· 1 year agoWhatever your investment style or strategy, there's no denying that tried-and true dividend stocks can be a superb addition to any portfolio. Companies...
Olema (OLMA) Up on FDA Fast Track Tag for Breast Cancer Drug
Zacks via Yahoo Finance· 2 years agoThe FDA bestows a Fast Track designation to Olema's (OLMA) novel pipeline candidate, OP-1250, for...
Long-Term Returns of Scott Ferguson Activist Targets
Insider Monkey via Yahoo Finance· 8 months agoIn this article, we discuss long-term returns of Scott Ferguson’s activist targets. If you want to see more stocks in this selection, check out Long Term...
Why Shares of ProKidney Were Dropping Thursday
Motley Fool· 7 months agoShares of ProKidney (NASDAQ: PROK) were down more than 33% as of 2 p.m. ET on Thursday. ProKidney is a clinical-stage biotech company that focuses on the...
